Zentalis Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MATRIX CAPITAL MANAGEMENT COMPANY, LP | 11/13/2025 | 13.96 M | $21.08 M | 0.00% | 19.39% |
| VANGUARD GROUP INC | 11/07/2025 | 2.90 M | $4.39 M | 0.69% | 4.03% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 2.85 M | $4.29 M | 1.65% | 3.95% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 2.33 M | $3.51 M | 52.03% | 3.23% |
| CITADEL ADVISORS LLC | 11/14/2025 | 2.08 M | $3.14 M | 349.30% | 2.89% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.55 M | $2.34 M | 0.00% | 2.15% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.55 M | $2.34 M | 117.12% | 2.15% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 1.46 M | $2.21 M | 14.52% | 2.03% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 1.41 M | $2.13 M | 17.63% | 1.96% |
| MORGAN STANLEY | 11/14/2025 | 1.41 M | $2.13 M | 28.26% | 1.96% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 1.36 M | $2.06 M | 24.73% | 1.89% |
| DECHENG CAPITAL LLC | 11/14/2025 | 1.32 M | $2.00 M | 0.00% | 1.84% |
| BLACKROCK, INC. | 11/12/2025 | 1.25 M | $1.89 M | -28.26% | 1.74% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 1.19 M | $1.79 M | 22.11% | 1.65% |
| GSA CAPITAL PARTNERS LLP | 11/07/2025 | 1.08 M | $1.63 M | -4.92% | 1.50% |
| PRIMECAP MANAGEMENT CO/CA/ | 11/12/2025 | 962.62 K | $1.45 M | -6.33% | 1.34% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 11/06/2025 | 961.49 K | $1.45 M | -34.95% | 1.34% |
| PFIZER INC | 11/13/2025 | 953.83 K | $1.44 M | 0.00% | 1.32% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 902.52 K | $1.36 M | -74.04% | 1.25% |
| JPMORGAN CHASE & CO | 11/26/2025 | 723.08 K | $1.09 M | 31.36% | 1.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/17/2025 | 700.58 K | $1.06 M | -18.31% | 0.97% |
| JANE STREET GROUP, LLC | 11/14/2025 | 645.62 K | $974.89 K | -2.78% | 0.90% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 589.22 K | $890.23 K | -4.68% | 0.82% |
| PEAPOD LANE CAPITAL LLC | 11/10/2025 | 565.37 K | $853.88 K | 1.10% | 0.79% |
| XTX TOPCO LTD | 11/14/2025 | 548.63 K | $828.43 K | 107.16% | 0.76% |
| UBS GROUP AG | 11/13/2025 | 532.68 K | $804.34 K | 311.44% | 0.74% |
| WOODLINE PARTNERS LP | 11/14/2025 | 530.58 K | $801.18 K | 0.00% | 0.74% |
| 5AM VENTURE MANAGEMENT, LLC | 11/14/2025 | 490.00 K | $739.90 K | 0.00% | 0.68% |
| ALMITAS CAPITAL LLC | 11/17/2025 | 457.32 K | $690.56 K | -71.40% | 0.64% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 11/13/2025 | 453.80 K | $685.24 K | 316.29% | 0.63% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/13/2025 | 380.82 K | $575.04 K | 20.96% | 0.53% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 345.16 K | $521.18 K | -59.95% | 0.48% |
| OPALEYE MANAGEMENT INC. | 11/14/2025 | 316.55 K | $477.99 K | -83.55% | 0.44% |
| STATE STREET CORP | 11/14/2025 | 271.79 K | $410.40 K | 0.00% | 0.38% |
| CREATIVE PLANNING | 11/14/2025 | 260.00 K | $392.60 K | 756.95% | 0.36% |
| FMR LLC | 11/13/2025 | 203.31 K | $306.99 K | 10.09% | 0.28% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 201.11 K | $303.68 K | 37.96% | 0.28% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 185.03 K | $279.38 K | -44.93% | 0.26% |
| INVESCO LTD. | 11/13/2025 | 173.62 K | $262.17 K | 11.50% | 0.24% |
| SEI INVESTMENTS CO | 11/13/2025 | 167.10 K | $252.32 K | 0.00% | 0.23% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 10/29/2025 | 166.29 K | $257.75 K | -4.43% | 0.23% |
| BARCLAYS PLC | 11/12/2025 | 161.47 K | $243.82 K | 100.00% | 0.22% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 158.94 K | $239.99 K | -8.39% | 0.22% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 152.15 K | $229.74 K | 328.89% | 0.21% |
| WALLEYE CAPITAL LLC | 11/14/2025 | 120.45 K | $181.88 K | -7.25% | 0.17% |
| QUARRY LP | 11/14/2025 | 108.75 K | $164.21 K | 3.57% | 0.15% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 106.97 K | $161.52 K | -75.41% | 0.15% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2025 | 97.90 K | $147.83 K | 100.00% | 0.14% |
| NORTHERN TRUST CORP | 11/14/2025 | 94.12 K | $142.12 K | -23.76% | 0.13% |
| RBF CAPITAL, LLC | 11/14/2025 | 80.00 K | $120.80 K | 0.00% | 0.11% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Zentalis Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 140 institutional investors and hedge funds held shares of Zentalis Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Matrix Capital Management Company, LP: 13.96 M
VANGUARD GROUP INC: 2.9 M
ACADIAN ASSET MANAGEMENT LLC: 2.85 M
RENAISSANCE TECHNOLOGIES LLC: 2.33 M
CITADEL ADVISORS LLC: 2.08 M
TANG CAPITAL MANAGEMENT LLC: 1.55 M
73.30% of Zentalis Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 61.39 M shares in the last 24 months. This purchase volume represents approximately $98.84 M in transactions.